Apellis Pharmaceuticals Inc
(APLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,878 | -528,628 | -652,172 | -746,354 | -344,874 |
| Depreciation Amortization | 12,292 | 28,077 | 28,928 | 3,648 | 16,395 |
| Accounts receivable | -58,484 | -198,715 | 2,375 | -10,103 | 0 |
| Accounts payable and accrued liabilities | 1,089 | 170 | 18,689 | 10,487 | -54 |
| Other Working Capital | -18,357 | -200,249 | -15,763 | -93,522 | 19,586 |
| Other Operating Activity | 173,472 | 304,610 | 104,198 | 272,718 | 148,459 |
| Operating Cash Flow | $-87,866 | $-594,735 | $-513,745 | $-563,126 | $-160,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -403 | -674 | -1,524 | -1,103 | -5,422 |
| Purchase Of Investment | N/A | N/A | -331,863 | -171,281 | -879,067 |
| Sale Of Investment | N/A | N/A | 393,280 | 420,000 | 567,500 |
| Investing Cash Flow | $-403 | $-674 | $59,893 | $247,616 | $-316,989 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 365,454 | N/A | N/A | N/A | 322,874 |
| Common Stock Issued | 18,828 | 461,039 | 405,841 | 398,024 | 392,416 |
| Other Financing Activity | -235,041 | -66,540 | -40,182 | -5,788 | -23,112 |
| Financing Cash Flow | $149,241 | $394,499 | $365,659 | $392,236 | $692,178 |
| Exchange Rate Effect | -659 | 135 | -488 | -2,016 | 359 |
| Beginning Cash Position | 352,299 | 553,074 | 641,755 | 567,045 | 351,985 |
| End Cash Position | 412,612 | 352,299 | 553,074 | 641,755 | 567,045 |
| Net Cash Flow | $60,313 | $-200,775 | $-88,681 | $74,710 | $215,060 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,866 | -594,735 | -513,745 | -563,126 | -160,488 |
| Capital Expenditure | -403 | -773 | -1,524 | -1,103 | -5,422 |
| Free Cash Flow | -88,269 | -595,508 | -515,269 | -564,229 | -165,910 |